Mounjaro is also a GLP-1 RA but slightly different in that it targets both GLP-1 (glucagon like peptide) and another hormone, GIP (glucagon dependent insulinotropic polypeptide)
Ultimately, these mechanistic benefits play out in clinical trials, where ALCAR supplementation has been shown to improve cognitive function and slow neurodegeneration [22]
Overall, that equated to a tiny decrease in density and no clear or statistically significant evidence of real bone loss
Strengthening the protective barrier
Chemotherapy, in particular, can influence blood sugar levels, causing fluctuations that need careful consideration
The GRADE assessment showed moderate certainty of evidence for the increase in serum vitamin B12 levels and low certainty of evidence for homocysteine reduction, both across all studies and within RCT-only and observational-only subgroups